Overview

Pharmacokinetics and Safety Profile of CKD-333

Status:
Completed
Trial end date:
2018-10-12
Target enrollment:
Participant gender:
Summary
Compare the pharmacokinetic characteristics and safety between CKD-333 tablet and CKD-330, D086 combination
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical